Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111393412A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111393412A details a high-yield refining method for Dabigatran Etexilate using acetone/water and ethyl acetate, ensuring >99.7% purity for reliable API supply chains.